The NIDCR is offering a grant for planning and implementing clinical trials related to its mission. This phased cooperative agreement includes a one-year planning phase (UG3) and a possible transition to a five-year clinical trial implementation phase (UH3). Only projects meeting scientific milestones can progress to the implementation phase. The grant application combines UG3 and UH3 phases in a single submission. The UH3 phase supports one investigator-initiated clinical trial. Applications are due by January 8, 2025.
Opportunity ID: 331912
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-160 |
| Funding Opportunity Title: | NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 05, 2021 |
| Last Updated Date: | May 22, 2024 |
| Original Closing Date for Applications: | May 07, 2024 |
| Current Closing Date for Applications: | Jan 08, 2025 |
| Archive Date: | Feb 07, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts Native American tribal governments (Federally recognized) Special district governments Public and State controlled institutions of higher education Private institutions of higher education County governments State governments For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to seek UG3/UH3 phased cooperative agreement research applications to plan and implement clinical trials within the mission of NIDCR. Awards made under this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible transition to a clinical trial implementation phase of up to five years (UH3). Only UG3 projects that have met the scientific milestones and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA. The UH3 phase of the award will support the conduct of one investigator-initiated clinical trial. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-160.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| updated close date | May 22, 2024 | |
| Mar 05, 2021 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-160 |
| Funding Opportunity Title: | NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 05, 2021 |
| Last Updated Date: | May 22, 2024 |
| Original Closing Date for Applications: | May 07, 2024 |
| Current Closing Date for Applications: | Jan 08, 2025 |
| Archive Date: | Feb 07, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts Native American tribal governments (Federally recognized) Special district governments Public and State controlled institutions of higher education Private institutions of higher education County governments State governments For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to seek UG3/UH3 phased cooperative agreement research applications to plan and implement clinical trials within the mission of NIDCR. Awards made under this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible transition to a clinical trial implementation phase of up to five years (UH3). Only UG3 projects that have met the scientific milestones and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA. The UH3 phase of the award will support the conduct of one investigator-initiated clinical trial. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-160.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-160 |
| Funding Opportunity Title: | NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 05, 2021 |
| Last Updated Date: | Mar 05, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 07, 2024 |
| Archive Date: | Jun 12, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments Special district governments County governments Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Independent school districts Public and State controlled institutions of higher education Small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to seek UG3/UH3 phased cooperative agreement research applications to plan and implement clinical trials within the mission of NIDCR. Awards made under this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible transition to a clinical trial implementation phase of up to five years (UH3). Only UG3 projects that have met the scientific milestones and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA. The UH3 phase of the award will support the conduct of one investigator-initiated clinical trial. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-160.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
Folder 331912 Full Announcement-PAR-21-160 -> PAR-21-160-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020Do not use. Must use FORMS-F-REVISED form package for all submissions to PAR-21-160 | PKG00265814 | May 08, 2021 | May 10, 2021 | View | |
| FORMS-F-REVISED | Use for due dates on or before January 24, 2022 | PKG00265872 | Mar 10, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270461 | Nov 18, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00278431 | Nov 15, 2022 | Jan 24, 2025 | View |
Package 1
Mandatory forms
331912 RR_SF424_2_0-2.0.pdf
331912 PHS398_CoverPageSupplement_5_0-5.0.pdf
331912 RR_OtherProjectInfo_1_4-1.4.pdf
331912 PerformanceSite_2_0-2.0.pdf
331912 RR_KeyPersonExpanded_2_0-2.0.pdf
331912 RR_Budget_1_4-1.4.pdf
331912 PHS398_ResearchPlan_4_0-4.0.pdf
331912 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
331912 RR_SubawardBudget30_1_4-1.4.pdf
331912 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
331912 RR_SF424_2_0-2.0.pdf
331912 PHS398_CoverPageSupplement_5_0-5.0.pdf
331912 RR_OtherProjectInfo_1_4-1.4.pdf
331912 PerformanceSite_2_0-2.0.pdf
331912 RR_KeyPersonExpanded_2_0-2.0.pdf
331912 RR_Budget10_1_4-1.4.pdf
331912 PHS398_ResearchPlan_4_0-4.0.pdf
331912 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
331912 RR_SubawardBudget10_30_1_4-1.4.pdf
331912 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
331912 RR_SF424_5_0-5.0.pdf
331912 PHS398_CoverPageSupplement_5_0-5.0.pdf
331912 RR_OtherProjectInfo_1_4-1.4.pdf
331912 PerformanceSite_4_0-4.0.pdf
331912 RR_KeyPersonExpanded_4_0-4.0.pdf
331912 RR_Budget10_3_0-3.0.pdf
331912 PHS398_ResearchPlan_4_0-4.0.pdf
331912 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
331912 RR_SubawardBudget10_30_3_0-3.0.pdf
331912 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 4
Mandatory forms
331912 RR_SF424_5_0-5.0.pdf
331912 PHS398_CoverPageSupplement_5_0-5.0.pdf
331912 RR_OtherProjectInfo_1_4-1.4.pdf
331912 PerformanceSite_4_0-4.0.pdf
331912 RR_KeyPersonExpanded_4_0-4.0.pdf
331912 RR_Budget10_3_0-3.0.pdf
331912 PHS398_ResearchPlan_5_0-5.0.pdf
331912 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
331912 RR_SubawardBudget10_30_3_0-3.0.pdf
331912 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
